The growing morbidity, mortality, and health care costs related to heart failure (HF) underscore the urgent need to ...

Boehringer Ingelheim and Eli Lilly have published data for their SGLT2 inhibitor Jardiance in acute heart failure ... Lilly booked $1.5 billion from the SGLT2 inhibitor last year, up 29%, and ...

The HFpEF Summit is a biannual, two-day meeting bringing together internationally recognized leaders in the clinical, biological, and translational study of HFpEF. This summit focused on the latest ...

According to the American Heart Association, about 1 in 3 adults – roughly ... stage 1 (excess weight), stage 2 (metabolic risk factors and kidney disease), stage 3 (subclinical cardiovascular ...

An international team of researchers has discovered a natural mechanism that protects the heart from heart failure with preserved ejection fraction (HFpEF), a serious condition in need of effective ...